{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:20:06Z","timestamp":1791390006108,"version":"4.3.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["NCKUH-11202044"],"award-info":[{"award-number":["NCKUH-11202044"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00277-024-06056-5","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:41:13Z","timestamp":1730104873000},"page":"5181-5189","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Predictors for spontaneous remission in childhood chronic immune thrombocytopenia"],"prefix":"10.1007","volume":"103","author":[{"given":"Yuan-Ning","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hsuan","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiann-Shiuh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3487-9511","authenticated-orcid":false,"given":"Chao-Neng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,27]]},"reference":[{"issue":"11","key":"6056_CR1","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1182\/blood-2008-07-162503","volume":"113","author":"F Rodeghiero","year":"2009","unstructured":"Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, Bussel JB, Cines DB, Chong BH, Cooper N, Godeau B, Lechner K, Mazzucconi MG, McMillan R, Sanz MA, Imbach P, Blanchette V, Kuhne T, Ruggeri M, George JN (2009) Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood 113(11):2386\u20132393. https:\/\/doi.org\/10.1182\/blood-2008-07-162503","journal-title":"Blood"},{"issue":"3","key":"6056_CR2","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1067\/s0022-3476(03)00245-2","volume":"143","author":"S Rosth\u00f8j","year":"2003","unstructured":"Rosth\u00f8j S, Hedlund-Treutiger I, Rajantie J, Zeller B, Jonsson OG, Elinder G, Wesenberg F, Henter J-I (2003) Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective nordic study of an unselected cohort. J Pediatr 143(3):302\u2013307. https:\/\/doi.org\/10.1067\/s0022-3476(03)00245-2","journal-title":"J Pediatr"},{"issue":"2","key":"6056_CR3","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/08035250410025294","volume":"94","author":"B Zeller","year":"2005","unstructured":"Zeller B, Rajantie J, Hedlund-Treutiger I, Tedg\u00e5rd U, Wesenberg F, Jonsson O, Henter JI, Rosth\u00f8j S (2005) Childhood idiopathic thrombocytopenic purpura in the nordic countries: Epidemiology and predictors of chronic disease. Acta Paediatr 94(2):178\u2013184. https:\/\/doi.org\/10.1080\/08035250410025294","journal-title":"Acta Paediatr"},{"issue":"4","key":"6056_CR4","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/pbc.21872","volume":"52","author":"H Donato","year":"2009","unstructured":"Donato H, Picon A, Martinez M, Rapetti MC, Rosso A, Gomez S, Rossi N, Bacciedoni V, Schvartzman G, Riccheri C, Costa A, Di Santo J (2009) Demographic data, natural history, and prognostic factors of idiopathic thrombocytopenic purpura in children: a multicentered study from Argentina. Pediatr Blood Cancer 52(4):491\u2013496. https:\/\/doi.org\/10.1002\/pbc.21872","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"6056_CR5","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/pbc.26178","volume":"64","author":"T Chotsampancharoen","year":"2017","unstructured":"Chotsampancharoen T, Sripornsawan P, Duangchoo S, Wongchanchailert M, McNeil E (2017) Predictive factors for resolution of childhood immune thrombocytopenia: experience from a single tertiary center in Thailand. Pediatr Blood Cancer 64(1):128\u2013134. https:\/\/doi.org\/10.1002\/pbc.26178","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"6056_CR6","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1542\/peds.2007-1129","volume":"121","author":"J Glanz","year":"2008","unstructured":"Glanz J, France E, Xu S, Hayes T, Hambidge S (2008) A population-based, multisite cohort study of the predictors of chronic idiopathic thrombocytopenic purpura in children. Pediatrics 121(3):e506\u2013512. https:\/\/doi.org\/10.1542\/peds.2007-1129","journal-title":"Pediatrics"},{"issue":"3","key":"6056_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.3390\/diagnostics13030341","volume":"13","author":"CN Cheng","year":"2023","unstructured":"Cheng CN, Yang YN, Yeh YH, Chen LW, Chen JS, Lin YC (2023) Predictors of remission in severe Childhood Immune Thrombocytopenia. Diagnostics (Basel) 13(3):341. https:\/\/doi.org\/10.3390\/diagnostics13030341","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"6056_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ajh.25479","volume":"94","author":"RF Grace","year":"2019","unstructured":"Grace RF, Shimano KA, Bhat R, Neunert C, Bussel JB, Klaassen RJ, Lambert MP, Rothman JA, Breakey VR, Hege K, Bennett CM, Rose MJ, Haley KM, Buchanan GR, Geddis A, Lorenzana A, Jeng M, Pastore YD, Crary SE, Neier M, Neufeld EJ, Neu N, Forbes PW, Despotovic JM (2019) Second-line treatments in children with immune thrombocytopenia: Effect on platelet count and patient-centered outcomes. Am J Hematol 94(7):741\u2013750. https:\/\/doi.org\/10.1002\/ajh.25479","journal-title":"Am J Hematol"},{"issue":"1","key":"6056_CR9","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/bjh.16751","volume":"191","author":"RF Grace","year":"2020","unstructured":"Grace RF, Klaassen RJ, Shimano KA, Lambert MP, Grimes A, Bussel JB, Breakey VR, Pastore YD, Black V, Overholt K, Bhat R, Forbes PW, Neunert C (2020) Fatigue in children and adolescents with immune thrombocytopenia. Br J Haematol 191(1):98\u2013106. https:\/\/doi.org\/10.1111\/bjh.16751","journal-title":"Br J Haematol"},{"issue":"6","key":"6056_CR10","doi-asserted-by":"publisher","first-page":"e29023","DOI":"10.1002\/pbc.29023","volume":"68","author":"KA Shimano","year":"2021","unstructured":"Shimano KA, Neunert C, Bussel JB, Klaassen RJ, Bhat R, Pastore YD, Lambert MP, Bennett CM, Despotovic JM, Forbes P, Grace RF (2021) Quality of life is an important indication for second-line treatment in children with immune thrombocytopenia. Pediatr Blood Cancer 68(6):e29023. https:\/\/doi.org\/10.1002\/pbc.29023","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"6056_CR11","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.3324\/haematol.2019.218883","volume":"104","author":"E Lucchini","year":"2019","unstructured":"Lucchini E, Zaja F, Bussel J (2019) Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019? Haematologica 104(6):1124\u20131135. https:\/\/doi.org\/10.3324\/haematol.2019.218883","journal-title":"Haematologica"},{"issue":"3","key":"6056_CR12","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/bjh.14261","volume":"175","author":"M Miano","year":"2016","unstructured":"Miano M, Ramenghi U, Russo G, Rubert L, Barone A, Tucci F, Farruggia P, Petrone A, Mondino A, Lo Valvo L, Crescenzio N, Bellia F, Olivieri I, Palmisani E, Caviglia I, Dufour C, Fioredda F (2016) Mycophenolate mofetil for the treatment of children with immune thrombocytopenia and Evans syndrome. A retrospective data review from the Italian association of paediatric haematology\/oncology. Br J Haematol 175(3):490\u2013495. https:\/\/doi.org\/10.1111\/bjh.14261","journal-title":"Br J Haematol"},{"issue":"8","key":"6056_CR13","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1002\/pbc.26003","volume":"63","author":"C Neunert","year":"2016","unstructured":"Neunert C, Despotovic J, Haley K, Lambert MP, Nottage K, Shimano K, Bennett C, Klaassen R, Stine K, Thompson A, Pastore Y, Brown T, Forbes PW, Grace RF (2016) Thrombopoietin receptor agonist use in children: data from the Pediatric ITP Consortium of North America ICON2 study. Pediatr Blood Cancer 63(8):1407\u20131413. https:\/\/doi.org\/10.1002\/pbc.26003","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"6056_CR14","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3324\/haematol.2012.075648","volume":"98","author":"N Vianelli","year":"2013","unstructured":"Vianelli N, Palandri F, Polverelli N, Stasi R, Joelsson J, Johansson E, Ruggeri M, Zaja F, Cantoni S, Catucci AE, Candoni A, Morra E, Bj\u00f6rkholm M, Baccarani M, Rodeghiero F (2013) Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years. Haematologica 98(6):875\u2013880. https:\/\/doi.org\/10.3324\/haematol.2012.075648","journal-title":"Haematologica"},{"issue":"5","key":"6056_CR15","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/bjh.16448","volume":"189","author":"S Ducassou","year":"2020","unstructured":"Ducassou S, Gourdonneau A, Fernandes H, Leverger G, Pasquet M, Fouyssac F, Bayart S, Bertrand Y, Michel G, Jeziorski E, Thomas C, Abouchallah W, Viard F, Guitton C, Cheikh N, Pellier I, Carausu L, Droz C, Leblanc T, Aladjidi N (2020) Second-line treatment trends and long-term outcomes of 392 children with chronic immune thrombocytopenic purpura: the French experience over the past 25 years. Br J Haematol 189(5):931\u2013942. https:\/\/doi.org\/10.1111\/bjh.16448","journal-title":"Br J Haematol"},{"key":"6056_CR16","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jpeds.2020.12.018","volume":"231","author":"S Ducassou","year":"2021","unstructured":"Ducassou S, Fernandes H, Savel H, Bertrand Y, Leblanc T, Abou Chahla W, Pasquet M, Leverger G, Barlogis V, Thomas C, Bayart S, Pellier I, Armari-Alla C, Guitton C, Cheikh N, Kherfellah D, Vassal G, Thi\u00e9baut R, Laghouati S, Aladjidi N (2021) Prospective evaluation of the first option, second-line therapy in Childhood Chronic Immune Thrombocytopenia: splenectomy or Immunomodulation. J Pediatr 231:223\u2013230. https:\/\/doi.org\/10.1016\/j.jpeds.2020.12.018","journal-title":"J Pediatr"},{"issue":"3","key":"6056_CR17","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1182\/blood.2022015508","volume":"140","author":"T Pincez","year":"2022","unstructured":"Pincez T, Aladjidi N, H\u00e9ritier S, Garnier N, Fahd M, Abou Chahla W, Fernandes H, Dichamp C, Ducassou S, Pasquet M, Bayart S, Moshous D, Cheikh N, Paillard C, Plantaz D, Jeziorski E, Thomas C, Guitton C, Deparis M, Marie Cardine A, Stephan JL, Pellier I, Dor\u00e9 E, Benadiba J, Pluchart C, Briandet C, Barlogis V, Leverger G, Leblanc T (2022) Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias. Blood 140(3):253\u2013261. https:\/\/doi.org\/10.1182\/blood.2022015508","journal-title":"Blood"},{"issue":"3","key":"6056_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/pbc.22346","volume":"54","author":"D Bansal","year":"2010","unstructured":"Bansal D, Bhamare TA, Trehan A, Ahluwalia J, Varma N, Marwaha RK (2010) Outcome of chronic idiopathic thrombocytopenic purpura in children. Pediatr Blood Cancer 54(3):403\u2013407. https:\/\/doi.org\/10.1002\/pbc.22346","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"6056_CR19","doi-asserted-by":"publisher","first-page":"e26598","DOI":"10.1002\/pbc.26598","volume":"64","author":"T Chotsampancharoen","year":"2017","unstructured":"Chotsampancharoen T, Sripornsawan P, Duangchoo S, Wongchanchailert M, McNeil E (2017) Clinical outcome of childhood chronic immune thrombocytopenia: a 38-year experience from a single tertiary center in Thailand. Pediatr Blood Cancer 64(11):e26598. https:\/\/doi.org\/10.1002\/pbc.26598","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"6056_CR20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1111\/j.1651-2227.2012.02671.x","volume":"101","author":"S Rosth\u00f8j","year":"2012","unstructured":"Rosth\u00f8j S, Rajantie J, Treutiger I, Zeller B, Tedg\u00e5rd U, Henter JI (2012) Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a nordic cohort. Acta Paediatr 101(7):761\u2013766. https:\/\/doi.org\/10.1111\/j.1651-2227.2012.02671.x","journal-title":"Acta Paediatr"},{"issue":"1","key":"6056_CR21","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3349\/ymj.2016.57.1.127","volume":"57","author":"CY Kim","year":"2016","unstructured":"Kim CY, Lee EH, Yoon HS (2016) High remission rate of Chronic Immune Thrombocytopenia in Children: result of 20-Year Follow-Up. Yonsei Med J 57(1):127\u2013131. https:\/\/doi.org\/10.3349\/ymj.2016.57.1.127","journal-title":"Yonsei Med J"},{"issue":"5 Suppl","key":"6056_CR22","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1002\/pbc.20970","volume":"47","author":"R Hazzan","year":"2006","unstructured":"Hazzan R, Mukamel M, Yacobovich J, Yaniv I, Tamary H (2006) Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura. Pediatr Blood Cancer 47(5 Suppl):657\u2013659. https:\/\/doi.org\/10.1002\/pbc.20970","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"6056_CR23","doi-asserted-by":"publisher","first-page":"e29146","DOI":"10.1002\/pbc.29146","volume":"68","author":"S Kittivisuit","year":"2021","unstructured":"Kittivisuit S, Vachvanichsanong P, McNeil E, Chotsampancharoen T (2021) Childhood-onset systemic lupus erythematosus and immune thrombocytopenia: prevalence and risk factors. Pediatr Blood Cancer 68(8):e29146. https:\/\/doi.org\/10.1002\/pbc.29146","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"6056_CR24","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00043426-199707000-00006","volume":"19","author":"SA Zimmerman","year":"1997","unstructured":"Zimmerman SA, Ware RE (1997) Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura. J Pediatr Hematol Oncol 19(4):297\u2013303. https:\/\/doi.org\/10.1097\/00043426-199707000-00006","journal-title":"J Pediatr Hematol Oncol"},{"issue":"7","key":"6056_CR25","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1007\/s00277-022-04836-5","volume":"101","author":"Y Song","year":"2022","unstructured":"Song Y, Zhang Y, Li Z, Liu J, Xiao J, Song H (2022) Potential risk factors for the development from immune thrombocytopenia to systemic lupus erythematosus: a case-control study in Chinese children. Ann Hematol 101(7):1447\u20131456. https:\/\/doi.org\/10.1007\/s00277-022-04836-5","journal-title":"Ann Hematol"},{"issue":"2","key":"6056_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11239-007-0031-y","volume":"24","author":"A Altintas","year":"2007","unstructured":"Altintas A, Ozel A, Okur N, Okur N, Cil T, Pasa S, Ayyildiz O (2007) Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura. J Thromb Thrombolysis 24(2):163\u2013168. https:\/\/doi.org\/10.1007\/s11239-007-0031-y","journal-title":"J Thromb Thrombolysis"},{"key":"6056_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26900","author":"T Pincez","year":"2023","unstructured":"Pincez T, Fernandes H, Pasquet M, Abou Chahla W, Granel J, H\u00e9ritier S, Fahd M, Ducassou S, Thomas C, Garnier N, Barlogis V, Jeziorski E, Bayart S, Chastagner P, Cheikh N, Guitton C, Paillard C, Lejeune J, Millot F, Li-Thiao Te V, Mallebranche C, Pellier I, Neven B, Armari-Alla C, Carausu L, Piguet C, Benadiba J, Pluchart C, Stephan JL, Deparis M, Briandet C, Dor\u00e9 E, Marie-Cardine A, Leblanc T, Leverger G, Aladjidi N (2023) Impact of age at diagnosis, sex, and immunopathological manifestations in 886 patients with pediatric chronic immune thrombocytopenia. Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.26900","journal-title":"Am J Hematol"},{"issue":"2","key":"6056_CR28","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2009-06-225565","volume":"115","author":"D Provan","year":"2010","unstructured":"Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ (2010) International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 115(2):168\u2013186. https:\/\/doi.org\/10.1182\/blood-2009-06-225565","journal-title":"Blood"},{"issue":"9","key":"6056_CR29","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725. https:\/\/doi.org\/10.1002\/art.1780400928","journal-title":"Arthritis Rheum"},{"issue":"8","key":"6056_CR30","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1177\/000992280404300802","volume":"43","author":"RG Watts","year":"2004","unstructured":"Watts RG (2004) Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama. Clin Pediatr (Phila) 43(8):691\u2013702. https:\/\/doi.org\/10.1177\/000992280404300802","journal-title":"Clin Pediatr (Phila)"},{"issue":"5 Suppl","key":"6056_CR31","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/pbc.20995","volume":"47","author":"J Roganovic","year":"2006","unstructured":"Roganovic J, Letica-Crepulja M (2006) Idiopathic thrombocytopenic purpura: a 15-year natural history study at the children\u2019s Hospital Rijeka, Croatia. Pediatr Blood Cancer 47(5 Suppl):662\u2013664. https:\/\/doi.org\/10.1002\/pbc.20995","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"6056_CR32","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5045\/br.2014.49.3.187","volume":"49","author":"YJ Shim","year":"2014","unstructured":"Shim YJ, Kim UH, Suh JK, Lee KS (2014) Natural course of childhood chronic immune thrombocytopenia using the revised terminology and definitions of the international working group: a single center experience. Blood Res 49(3):187\u2013191. https:\/\/doi.org\/10.5045\/br.2014.49.3.187","journal-title":"Blood Res"},{"issue":"23","key":"6056_CR33","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","volume":"3","author":"C Neunert","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, Buchanan G, Cines DB, Cooper N, Cuker A, Despotovic JM, George JN, Grace RF, Kuhne T, Kuter DJ, Lim W, McCrae KR, Pruitt B, Shimanek H, Vesely SK (2019) American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv 3(23):3829\u20133866. https:\/\/doi.org\/10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"issue":"22","key":"6056_CR34","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","volume":"3","author":"D Provan","year":"2019","unstructured":"Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, Gonzalez-Lopez TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ (2019) Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv 3(22):3780\u20133817. https:\/\/doi.org\/10.1182\/bloodadvances.2019000812","journal-title":"Blood Adv"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-024-06056-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-024-06056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T01:12:01Z","timestamp":1735866721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-024-06056-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,27]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["6056"],"URL":"https:\/\/doi.org\/10.1007\/s00277-024-06056-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,27]]},"assertion":[{"value":"19 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Institutional Review Board of National Cheng Kung University Hospital (A-ER-111-141).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The patient\u2019s consent was waived for retrospective study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}